Veterinary medicine European public assessment report (EPAR): Vectormune ND, Newcastle disease and Marek’s disease vaccine (live recombinant), Revision: 3, Authorised

10:00 EDT 31 Jul 2018 | European Medicines Agency

More From BioPortfolio on "Veterinary medicine European public assessment report (EPAR): Vectormune ND, Newcastle disease and Marek’s disease vaccine (live recombinant), Revision: 3, Authorised"